From new centres and equipment to the latest in care, stay on top with what we are doing
Karthik Ramasamy MBBS, FRCP, FRCPath, PhD. GenesisCare’s new Clinical Director for Haematology Services
20 December, 2018
Karthik is a Consultant Haematologist at Oxford University Hospitals NHS Trust and GenesisCare’s new Clinical Director for haematology services. Karthik is also the Director of the Oxford Myeloma Translational Research Centre, the Lead Clinician for myeloma and other plasma cell dyscrasias at the Thames Valley Strategic Clinical Network, Divisional Lead for Cancer research for National…
An innovative treatment technique for suitable left-sided breast cancer patients has officially launched in regional Queensland. The best practice technique called deep inspiration breath hold (DIBH) reduces the effects of radiotherapy on the heart to minimise the risk of long-term side effects. GenesisCare is now providing the service at its new radiation oncology centres co-located…
Sydney-headquartered GenesisCare, the largest private provider of cancer and cardiac healthcare in Australia and Europe, announced today that it had completed a major capital raising, including a refinancing of debt facilities, while securing a second major investor. New funds raised will be directed towards GenesisCare’s core mission of improving patient access and raising the standard…
New cancer centre in Concord announced, to respond to Canada Bay Local Government Area’s high priority need for a new radiotherapy service State-of-the-art facility to open mid-2019 and will be equipped to deliver up to 16,200 radiotherapy and chemotherapy treatments for up to 1,100 cancer patients annually GenesisCare has officially started construction on a comprehensive…
James is a consultant oncologist with a special interest in gastro-intestinal and head/neck cancers at the Queen Elizabeth Hospital, Birmingham. He has a particular focus on precision radiotherapy for liver/pancreas tumours and clinical trials. James recently joined GenesisCare as clinical director of stereotactic radiotherapy, and sees patients at GenesisCare Birmingham and GenesisCare Oxford. Here he…
New agreement expands access to precision radiotherapy for people with cancer ViewRay, Inc. (Nasdaq: VRAY) today announced a collaboration with GenesisCare, the largest provider of cancer services in the UK, Spain and Australia, to introduce the first MRIdian MRI-guided radiotherapy system in the UK to benefit cancer patients. As part of the formal agreement, multiple…
We use cookies on our site to track site traffic and deliver the best experience. If you’d like to know more visit our privacy policy. Thanks.OkPrivacy policy
